The ENIGMA consortium (http://enigma.ini.usc.edu/) was established to investigate brain structure, function, and disease by combining genomic and neuroimaging datasets from multiple sites. Its goal is to maximize statistical power and the yield from existing datasets through very large data pooling efforts. This goal has added importance today in light of concerns over the rigor and reproducibility of many neuroimaging and genomic findings. Since its initial successes (a genome wide association study on subcortical volumes with over 26,000 participants, Stein et al., 2012 Nature Genetics), a number of working groups have been established which use the standardized multi-site ENIGMA preprocessing pipelines and analytic methods to study the neurobiology of specific diseases. This application's PIs created the ENIGMA Addiction working group which now has access to datasets representing over 14000 participants. Genomic and neuromaging analyses on this unprecedented collection of data should produce important new insights into the neural and genetic basis of addiction. Building on our initial proof of concept funding (R21DA038381), we propose to further expand the Addiction working group which currently includes only a fraction of the world's potential relevant datasets, to identify robust brain markers of dependence for genetic association analyses, and to examine genetic and brain markers for the transition between stages of substance use across the lifespan. We will also increase the range of brain measures examined to include structural and functional connectivity (DTI and resting-state data) and will develop morphometric analyses of brain structures. We can use these biomarkers to assess if brain alterations preceded dependence or arose during early or chronic use and if these effects correct with abstinence by exploiting the familial, developmental, longitudinal and abstinence samples in our working group. We will create a data analysis portal that will provide both wide access to the pooled data and optimized analytic methods that maximize rigor and reproducibility (e.g., appropriate covariates, nested variance models, propensity weighting for sociodemographics, cross-validation) thereby guiding others to use these data appropriately and wisely. The analysis portal will archive analyses (e.g., exact subjects and analysis scripts) to ensure best practice and full transparency. We will actively work to expand the consortium to create a uniquely large neuroimaging-genetic addiction dataset and we will make results freely available to the research community through the online interactive tool ENIGMA-Vis (http://enigma.ini.usc.edu/enigma-vis/).
The ENIGMA-Addiction consortium (http://enigma.ini.usc.edu/) was established to understand the genomic and neurobiological correlates of substance abuse by combining existing genomic and brain imaging datasets. Its goal is to maximize the yield from existing datasets through very large data pooling efforts thereby providing statistical power for rigorous and reproducible analyses. This application seeks to develop this consortium beyond its proof-of-concept stage by identifying genetic and environmental influences on brain markers of dependence using an expanded number of brain measures and to make the data available through the creation of a data analysis portal.
